… acute respiratory syndrome coronavirus 2 (SARS-CoV-2) … drugs with potential activity against
SARS-CoV-2 at traditional and … putative binding sites across 23 SARS-CoV-2 proteins. We …

… magnitude is the Covid-19 epidemics caused by SARS-CoV-2. The aim of this study was to
… the SARS-CoV-2 that might be favoring human to human transmission. An in silico approach …

… binding of the major SARS-CoV-2 mRNAs to the … in silico study on the binding of all mRNAs
with the intracellular TLRs depicts that the mRNA of NSP10, S2, and E proteins of SARS-CoV…

Objectives Over the years, Azadirachta indica, Mangifera indica, and Moringa oleifera have
been shown to possess some antiviral characteristics. This study applies molecular docking …

… appropriate ligands and potential inhibitors against SARS-CoV-2.Studies have indicated …
SARS CoV-2. The screening of clinically approved drugs with the druggable target SARS-CoV-…

… respiratory syndrome coronavirus 2 (SARS-CoV-2) … SARS-CoV-2 genome and top miRNAs
targeting differentially expressed genes (DEGs) in lungs of patients infected with SARS-CoV-…

… SARS-CoV and SARS-CoV-2. More precisely, The binding of the spike S1 protein of SARS-CoV
and SARSCoV-… The receptor ACE2 in the SARS-CoV-2 causes the infection of the type II …

… including SARS‐CoV‐2 regarding efficacy, mechanisms and selective toxicity. The SARS‐CoV‐…
nuclear location signals for ivermectin and meta‐analyses for in vivo studies included all …

… applied for quantitative in silico analysis of SARS-CoV-2 S… analyzed based on the complex
structure of SARS-CoV-2 mutants and ACE-2. The downloaded stereo structure of SARS-CoV…

… a very systematic mutational analysis of SARS-CoV-2 genomes … analyzed 13 complete
sequences of SARS-CoV-2 reported from 13 different countries and compared with SARS-CoV…